- AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform
- Biomanufacturing company AbSci raises $12M to scale synthetic biology platform
- Osram strengthens portfolio for security applications via acquisition
- ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.
- Group14 Technologies Q&A with Dr. John Chen